Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
---|---|---|---|---|---|---|
1999 | Detection of a novel cytochrome P-450 1A2 polymorphism (F21L) in Chinese | Huang J.-D.; Guo W.-C.; Lai M.-D.; Yue Leon Guo ; Lambert G.H. | Drug Metabolism and Disposition | 52 | 44 | |
2005 | Effects of calcineurin inhibitors on sirolimus pharmacokinetics during staggered administration in renal transplant recipients | FE-LIN LIN WU ; MENG-KUN TSAI ; Rhei-Long Chen R.; Sun S.-W.; Huang J.-D.; REY-HENG HU ; Chen K.-H.; PO-HUANG LEE | Pharmacotherapy | 27 | 28 | |
2005 | Effects of conversion from sirolimus oral solution to tablets in stable Taiwanese renal transplant recipients | FE-LIN LIN WU ; MENG-KUN TSAI ; Sun S.-W.; Chen R.R.-L.; Huang J.-D.; PO-HUANG LEE | Journal of the Formosan Medical Association | 2 | 4 | |
1993 | Molecular basis of genetic variation in debrisoquin hydroxylation in Chinese subjects: Polymorphism in RFLP and DNA sequence of CYP2D6 | Wang S.-L.; Huang J.-D.; Lai M.-D.; Liu, Biing-Hui ; Lai M.-L. | Clinical Pharmacology & Therapeutics | 188 | 165 | |
1998 | The NAT2* slow acetylator genotype is associated with bladder cancer in Taiwanese, but not in the black foot disease endemic area population | Su H.J.; Yue Leon Guo ; Lai M.-D.; Huang J.-D.; YAWEN CHENG ; Christiani D.C. | Pharmacogenetics | 20 | 18 | |
2006 | Phase I and pharmacokinetic study of oral thalidomide in patients with advanced hepatocellular carcinoma | Shiah H.-S.; Chao Y.; Chen L.-T.; Yao T.-J.; Huang J.-D.; Chang J.-Y.; PEI-JER CHEN ; Chuang T.-R.; Chin Y.-H.; Whang-Peng J.; Liu T.-W. | Cancer Chemotherapy and Pharmacology | 11 | 12 | |
2018 | The ratio of pre-dialysis vancomycin trough serum concentration to minimum inhibitory concentration is associated with treatment outcomes in methicillin-resistant Staphylococcus aureus bacteremia | Fu C.-F.; Huang J.-D.; JANN-TAY WANG ; SHU-WEN LIN ; CHIEN-CHIH WU | PLoS ONE | 16 | 14 |